Thinking post-Paxlovid: Rutgers researchers eye the next generation of COVID drugs
Gothamist is a non-profit local newsroom, powered by WNYC.
Source: gothamist.com
📰 Simcere Pharmaceutical News
Simcere Pharmaceutical News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Simcere Pharmaceutical. Real-time updates on events, politics, business and more.
China Increases Merger Filing Thresholds | Skadden, Arps, Slate, Meagher & Flom LLP
China has finally published the long-awaited amendments to its merger control filing thresholds, which will materially impact companies considering mergers, acquisitions and joint...
United States South Korea Ministry Of Commerce On European Commission Meagher Flom Administration Of Foreign Exchange
Source: jdsupra.com
The year in review – a close look at China's merger control since the amendment of the Anti-Monopoly Law | Hogan Lovells
Looking back on the year 2023, this alert aims to give an update on the state of play in Chinese merger control. In particular, it looks at how merger control has evolved since China’s...
United States Broadcom Vmware Hague Apostille Administration For Market Regulation Hague Convention Anti Monopoly Law
Source: jdsupra.com
When Will New COVID-19 Antivirals Be Approved in the U.S.?
COVID-19 antivirals like simnotrelvir and ensitrelvir seem to work for more people than Paxlovid. But they're not approved in the U.S.
United States Eric Topol Stefan Sarafianos Simcere Pharmaceutical Scripps Research Translational Institute Emory University
Source: time.com
Innovation and Investment Propel DNA Encoded Library Market: AI Integration and Strategic Alliances Fuel Remarkable Growth
/PRNewswire/ -- The "DNA Encoded Library: Platforms and Services Market (2nd Edition), 2023-2035" report has been added to ResearchAndMarkets.coms offering....
Source: prnewswire.com
Acadia Pharmaceuticals Appoints Kevin R. Oliver, Ph.D., as Senior Vice President, Chief Business Off
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today the appointment of Dr. Kevin R. Oliver as Senior Vice President, Chief Business Officer, effective July 10, 2023. Dr. Oliver will oversee all business development functions and will serve as a member of the company’s Executive Man...
Source: pharmiweb.com
Acadia Pharmaceuticals Appoints Kevin R. Oliver, Ph.D., as Senior Vice President, Chief Business Officer
Acadia Pharmaceuticals Inc. announced today the appointment of Dr. Kevin R. Oliver as Senior Vice President, Chief Business Officer, effective July 10, 2023. Dr. Oliver will oversee all business...
Source: marketscreener.com
Four innovative drugs launched in three years, HKEX -Listed Simcere Pharmaceutical Group is on the Fast Track Toward Building an Innovation-Driven Global Pharmaceutical Company
/PRNewswire/ -- On Apr. 18, Simcere Pharmaceutical (2096.HK) disclosed the latest progress on the companys R&D and business operation on its first Investor...
Source: prnewswire.com
Past The Peak? Covid Drugs Frenzy Cools As Pandemic Eases
The drugs Xiannuoxin and Mindewei have been conditionally approved for marketing in China.
Simcere Xiannuoxin Merck Molnupiravir Junshi Biosciences Simcere Covid Ascletis Pharma Municipal Medical Insurance Bureau
Source: seekingalpha.com
Caixin Global - Latest Business and Financial News on China, U.S. Trade War and Negotiations, Breaking News, Headlines and Developments
Caixin Global provides the latest China news headlines on politics, economy, business and finance with insight and in-depth analysis.
Source: caixinglobal.com